Proteomics Market

Proteomics Market by Product (Spectroscopy, Chromatography, Electrophoresis, X-Ray Crystallography), Reagent, Service, (Core Proteomics, Bioinformatics), Application (Diagnostic, Drug Discovery), End User (Hospital, Labs, Biopharma) & Region - Global Forecast to 2028

Report Code: BT 2341 May, 2023, by marketsandmarkets.com

The global proteomics market in terms of revenue was estimated to be worth $36.8 billion in 2023 and is poised to reach $72.9 billion by 2028, growing at a CAGR of 14.6% from 2023 to 2028. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market. Various elements such as increasing R&D activities, increasing government funding for drug discovery research, and growing pharmaceutical & biological industries are the major growth factors for this market. Many proteomics-related research projects are also being fostered by increasing collaborative partnerships among various companies that are driving the gloal market growth.

Attractive Opportunities in the Proteomics Market

Proteomics Market

To know about the assumptions considered for the study, Request for Free Sample Report

Proteomics Market

Global Proteomics Market Dynamics

Driver: Technological Advancement in proteomics is likely to propel the global proteomics market growth

The field of proteomics has been revolutionized by technological advancements that have greatly improved sensitivity and resolution, allowed for high-throughput and multiplexed analysis, facilitated data integration, enhanced sample preparation and fractionation techniques, enabled mass spectrometry-based imaging, and provided advanced data analysis and informatics tools. These advancements have played a pivotal role in driving the growth of the market by enabling a thorough and comprehensive understanding of the proteome. They have accelerated biomarker discovery, propelled advancements in personalized medicine, and facilitated drug discovery and development. These technological advancements have expanded the capabilities of proteomics research, enabling comprehensive and in-depth exploration of proteins in various biological contexts. They have led to breakthroughs in understanding protein functions, disease mechanisms, drug discovery, and personalized medicine, driving the growth and impact of proteomics as a field of study.

Restraint: High costs of proteomics instruments and technologies

The use of proteomics research extends all the way from the discovery of novel drugs, vaccines, and diagnostic targets to the characterization of protein-based products, toxicology, and the identification of surrogate markers of activity in clinical research to provide information on the mechanisms of drug action. This requires the use of different types of platforms and instruments and laboratory documentation systems, software, and databases, contributing to the high cost of protein analytics. Also, proteomics experiments require specialized expertise in sample preparation, data analysis, and interpretation. This expertise can be scarce and expensive to hire, particularly for smaller organizations. Thus, the high cost of instruments can affect the growth of the market itself. Limited adoption due to cost constraints can slow down market expansion, affecting the development of new technologies, innovation, and competition among instrument manufacturers.

Opportunity: High growth opportunities for proteomics research in emerging countries

The Asia Pacific region has witnessed significant advancements in proteomic technologies and methodologies. Researchers in the region have adopted cutting-edge techniques, such as mass spectrometry, protein profiling, and protein interaction analysis, to investigate complex biological systems. The availability of state-of-the-art proteomics platforms and instruments has contributed to the growth of proteomics research and applications. Governments in the Asia Pacific region have implemented supportive policies and initiatives to promote scientific research and innovation, including proteomics. These initiatives include research grants, funding programs, and regulatory frameworks that encourage proteomics research and its translation into practical applications. Government support has fostered a favorable environment for the growth of proteomics in the region. Increasing competition in mature markets also compels manufacturers to focus on emerging markets to ensure stable revenue growth in the coming years.

Challenge: Lack of data management/handling in proteomics research

Proteomics is a rapidly expanding field, aided by improvements in instrumentation accuracy and sensitivity, size, and affordability. This offers many possibilities for personalized and precision medicine, which could improve diagnosis, treatment, and disease management in the coming years. However, with the increase in proteome analysis, there is an inevitable increase in the volume of data generated. Thus, managing and handling proteomics data requires specialized expertise, resources, and infrastructure. Addressing these challenges is critical for advancing proteomics research. Hence, it can be considered as a challenge for the market.

Global Proteomics Market Ecosystem

Proteomics Market Ecosystem

The spectroscopy segment dominated the proteomics industry in 2022.

Based on instrumentation technology, the proteomics market is broadly segmented into spectroscopy, chromatography, electrophoresis, protein microarrays, X-ray crystallography, surface plasmon resonance, protein fractionation, and other technologies. In 2022, spectroscopy accounted for the dominant share, segment's large share can be attributed to factors such as the increasing demand for spectroscopy techniques in proteomics research due to their ability to provide valuable insights into protein structure, dynamics, interactions, and functions. Furthermore, key market players are investing in drug discovery and development in the market is likely to spur the growth of the segment.

The immunoassay reagent segment of proteomics industry is expected to grow at the highest CAGR during the forecast period.

Based on reagents, the proteomics market is broadly segmented into protein microarray reagents, spectroscopy reagents, X-ray crystallography reagents, chromatography reagents, electrophoresis reagents, immunoassay reagents, protein fractionation reagents, and other reagents. The immunoassay reagent segment is expected to register the highest CAGR during the forecast period. The large share of the immunoassay reagents segment is attributed to the greater availability of a wide range of reagents and the increased need for reliable, specific, and fast detection of diseases at the early stages.

North America dominated the proteomics industry in 2022.

Proteomics Market by Region

To know about the assumptions considered for the study, download the pdf brochure

Geographically, the global proteomics market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. In 2022, North America accounted for the largest share in the market, followed by Europe and the Asia Pacific. The large share of the North American market is owing to various factors such presence of a large number of pharmaceutical companies and the growing demand for precision medicines. Increased research funding for proteomics is furthermore driving the global market growth in North America.

Key players in the proteomics market are Thermo Fisher Scientific, Inc. (US), Danaher Corporation (US), Merck KGaA (Germany), Agilent Technologies, Inc. (US), and Waters Corporation (US).

Scope of the Proteomics Industry:

Report Metric 

Details 

Market Revenue in 2023

$36.8 billion

Projected Revenue by 2028

$72.9 billion

Revenue Rate

Poised to Grow at a CAGR of 14.6%

Market Driver

Technological Advancement in proteomics is likely to propel the market growth

Market Opportunity

High growth opportunities for proteomics research in emerging countries

This report categorizes the global proteomics market to forecast revenue and analyze trends in each of the following submarkets:

By Instrumentation Technologies

  • Spectroscopy
    • Mass Spectrometry
    • NMR Spectroscopy
    • CD Spectroscopy
  • Chromatography
    • HPLC Chromatography
    • Ion Chromatography
    • Affinity Chromatography
    • Superficial Chromatography
  • Electrophoresis
    • Gel Electrophoresis
    • Capillary Electrophoresis
  • Protein Microarrays
    • Biochips
    • Microarray Instruments
  • X-Ray Crystallography
  • Surface Plasmon Resonance
  • Protein Fractionation
  • Other Technologies

By Reagent

  • Immunoassay Reagents
  • Spectroscopy Reagents
  • Chromatography Reagents
  • Protein Microarray Reagents
  • X-Ray Crystallography Reagents
  • Electrophoresis Reagents
  • Protein Fractionation Reagents
  • Other Reagents (Edman's reagent, enzymes, cross-linking agents)

By Software & Services

  • Core Proteomics Services
  • Bioinformatics Software & Services

By Application

  • Clinical Diagnostics
  • Drug Discovery & Development
  • Other Applications

By End User

  • Hospitals
  • Clinical Laboratories
  • Pharmaceutical & Biotechnology Companies
  • Academic Research Laboratories
  • Other End Users

By Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Recent Developments of Proteomics Industry

  • In February 2023, Waters Corporation acquired Wyatt Technology, which enhances the portfolio of Separation and Detection, which provides customers with an unmatched set of analytical solutions across a wide range of applications.
  • In October 2022, Agilent Technologies Inc. and CMP Scientific Corp. entered into a co-marketing agreement to provide an integrated capillary electrophoresis-mass spectrometry (CE-MS) solution for the life science and pharmaceutical industries.
  • In November 2021, Thermo Fisher Scientific acquired Belgium-based Pharmafluidics, the developer of the μPAC range of micro-chip-based chromatography columns. The µpac portfolio of columns enhances liquid chromatography (lc) performance in biomarker, proteomics, and drug r&d applications, helping biotechnology and pharmaceutical companies uncover new insights and advance scientific discovery.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS
 
1 INTRODUCTION (Page No. - 70)
    1.1 STUDY OBJECTIVES 
    1.2 MARKET DEFINITION AND SCOPE 
           1.2.1 INCLUSIONS AND EXCLUSIONS
           1.2.2 MARKETS COVERED
           1.2.3 YEARS CONSIDERED
    1.3 CURRENCY CONSIDERED 
    1.4 STAKEHOLDERS 
    1.5 RESEARCH LIMITATIONS 
    1.6 SUMMARY OF CHANGES 
    1.7 RECESSION IMPACT 

2 RESEARCH METHODOLOGY (Page No. - 76)
    2.1 RESEARCH DATA 
          FIGURE 1 RESEARCH DESIGN
           2.1.1 SECONDARY DATA
           2.1.2 PRIMARY DATA
                    FIGURE 2 PROTEOMICS MARKET SHARE: BREAKDOWN OF PRIMARIES
    2.2 PROTEOMICS MARKET SIZE ESTIMATION 
          FIGURE 3 PROTEOMICS MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2022
          FIGURE 4 PROTEOMICS MARKET SIZE ESTIMATION: APPROACH 1 (REVENUE SHARE ANALYSIS), 2022
          FIGURE 5 ILLUSTRATIVE EXAMPLE OF THERMO FISHER SCIENTIFIC INC.: REVENUE SHARE ANALYSIS, 2022
           2.2.1 INSIGHTS FROM PRIMARIES
                    FIGURE 6 MARKET VALIDATION FROM PRIMARY EXPERTS
           2.2.2 SEGMENT ASSESSMENT (BY PRODUCT, SOFTWARE & SERVICE, AND END USER)
                    FIGURE 7 PROTEOMICS MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
    2.3 GROWTH RATE ASSUMPTIONS 
          FIGURE 8 PROTEOMICS CRO MARKET: CAGR PROJECTIONS, 2023–2028
          FIGURE 9 PROTEOMICS CRO MARKET: GROWTH ANALYSIS OF DRIVERS, RESTRAINTS, CHALLENGES, AND OPPORTUNITIES
    2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 
          FIGURE 10 DATA TRIANGULATION METHODOLOGY
    2.5 STUDY ASSUMPTIONS 
    2.6 RISK ANALYSIS 
    2.7 IMPACT OF ECONOMIC RECESSION ON MARKET 
          TABLE 1 GLOBAL INFLATION RATE PROJECTIONS, 2024–2027 (% GROWTH)
          TABLE 2 US HEALTH EXPENDITURE, 2019–2027 (USD MILLION)
          TABLE 3 US HEALTH EXPENDITURE, 2023–2027 (USD MILLION)
 
3 EXECUTIVE SUMMARY (Page No. - 88)
    FIGURE 11 PROTEOMICS MARKET SHARE, BY INSTRUMENTATION TECHNOLOGY, 2023 VS. 2028 (USD MILLION)
    FIGURE 12 PROTEOMICS INUSTRY, BY REAGENT, 2023 VS. 2028 (USD MILLION)
    FIGURE 13 PROTEOMICS CRO MARKET, BY SOFTWARE & SERVICE, 2023 VS. 2028 (USD MILLION)
    FIGURE 14 MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)
    FIGURE 15 PROTEOMICS CRO MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
    FIGURE 16 GEOGRAPHICAL SNAPSHOT OF PROTEOMICS INUSTRY
 
4 PREMIUM INSIGHTS (Page No. - 93)
    4.1 OVERVIEW OF GLOBAL PROTEOMICS MARKET SHARE 
          FIGURE 17 RISING INVESTMENTS IN PHARMACEUTICAL R&D TO DRIVE MARKET
    4.2 NORTH AMERICA: MARKET SHARE, BY APPLICATION AND COUNTRY (2022) 
          FIGURE 18 CLINICAL DIAGNOSTICS ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN MARKET IN 2022
    4.3 ELECTROPHORESIS MARKET SHARE, BY TYPE, 2023 VS. 2028 (USD MILLION) 
          FIGURE 19 GEL ELECTROPHORESIS TO DOMINATE MARKET IN 2028
    4.4 PROTEOMICS CRO MARKET SHARE, BY END USER (2022) 
          FIGURE 20 PHARMACEUTICAL COMPANIES ACCOUNTED FOR LARGEST MARKET SHARE IN 2022
    4.5 PROTEOMICS INUSTRY: GEOGRAPHICAL GROWTH OPPORTUNITIES 
          FIGURE 21 ASIA PACIFIC TO REGISTER HIGHEST GROWTH IN MARKET DURING STUDY PERIOD
 
5 MARKET OVERVIEW (Page No. - 97)
    5.1 INTRODUCTION 
    5.2 MARKET DYNAMICS 
          FIGURE 22 GLOBAL PROTEOMICS MARKET SHARE: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
          TABLE 4 MARKET: IMPACT ANALYSIS
           5.2.1 DRIVERS
                    5.2.1.1 Increasing demand for personalized medicines for clinical practices
                                FIGURE 23 PERSONALIZED MEDICINES APPROVED BY FDA, 2015–2022
                    5.2.1.2 Rising incidences of chronic diseases among geriatric population
                    5.2.1.3 Increased investments in research and greater adoption of proteomics in drug discovery
                                FIGURE 24 GLOBAL SPENDING ON PHARMACEUTICAL R&D, 2015–2028 (USD BILLION)
                    5.2.1.4 Technological advancements in proteomics
           5.2.2 RESTRAINTS
                    5.2.2.1 High costs of proteomics instruments and technologies
                    5.2.2.2 Lack of standardization in proteomics workflow among research groups
           5.2.3 OPPORTUNITIES
                    5.2.3.1 High growth opportunities for proteomics research in emerging countries
                    5.2.3.2 Growing prominence of nano proteomics in biological processes
           5.2.4 CHALLENGES
                    5.2.4.1 Low biomarker discovery to approval ratio in proteomics research
                    5.2.4.2 Lack of data management/handling in proteomics research
    5.3 VALUE CHAIN ANALYSIS 
          FIGURE 25 VALUE CHAIN ANALYSIS: MANUFACTURING AND DISTRIBUTION PHASES PROVIDE MAXIMUM VALUE
    5.4 SUPPLY CHAIN ANALYSIS 
          FIGURE 26 PROTEOMICS CRO MARKET: SUPPLY CHAIN ANALYSIS
    5.5 ECOSYSTEM ANALYSIS 
          FIGURE 27 ECOSYSTEM ANALYSIS: MARKET
          TABLE 5 PROTEOMICS INUSTRY: ROLE IN ECOSYSTEM
    5.6 PORTER’S FIVE FORCES ANALYSIS 
          TABLE 6 MARKET: PORTER’S FIVE FORCES ANALYSIS
           5.6.1 THREAT OF NEW ENTRANTS
           5.6.2 THREAT OF SUBSTITUTES
           5.6.3 BARGAINING POWER OF SUPPLIERS
           5.6.4 BARGAINING POWER OF BUYERS
           5.6.5 INTENSITY OF COMPETITIVE RIVALRY
    5.7 PATENT ANALYSIS 
    5.8 PRICING ANALYSIS 
          TABLE 7 AVERAGE SELLING PRICE OF PROTEOMICS PRODUCTS (2022)
          TABLE 8 PERKINELMER: SELLING PRICE OF VARIOUS PRODUCTS/SERVICES
          TABLE 9 MERCK: SELLING PRICE OF VARIOUS PRODUCTS/SERVICES
    5.9 TECHNOLOGY ANALYSIS 
          TABLE 10 COMPARISON OF MODERN PROTEOMICS ANALYSIS METHODS
          TABLE 11 COMMONLY USED BIOINFORMATICS TOOLS IN PROTEOMICS
          TABLE 12 TECHNOLOGIES LAUNCHED RECENTLY IN PROTEOMICS
    5.10 REGULATORY ANALYSIS 
           5.10.1 REGULATIONS FOR PRODUCTS DEVELOPED USING PROTEOMICS TECHNIQUES
                     TABLE 13 KEY REGULATORY GUIDELINES FOR PROTEOMICS PRODUCTS
           5.10.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                     TABLE 14 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                     TABLE 15 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                     TABLE 16 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    5.11 KEY CONFERENCES AND EVENTS IN 2023 
           TABLE 17 PROTEOMICS CRO MARKET: DETAILED LIST OF CONFERENCES AND EVENTS IN 2023
    5.12 KEY STAKEHOLDERS AND BUYING CRITERIA 
           5.12.1 KEY STAKEHOLDERS IN BUYING PROCESS
                     FIGURE 28 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR APPLICATIONS
                     TABLE 18 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR APPLICATIONS
           5.12.2 BUYING CRITERIA
                     FIGURE 29 KEY BUYING CRITERIA FOR END USERS
    5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 
    5.14 TRADE ANALYSIS 
           5.14.1 TRADE ANALYSIS FOR ELECTROPHORESIS AND CHROMATOGRAPHY INSTRUMENTS
                     TABLE 19 IMPORT DATA FOR ELECTROPHORESIS AND CHROMATOGRAPHY INSTRUMENTS, BY COUNTRY, 2017–2021 (USD MILLION)
           5.14.2 TRADE ANALYSIS FOR DIAGNOSTICS AND LABORATORY REAGENTS
                     TABLE 20 IMPORT DATA FOR DIAGNOSTICS AND CLINICAL REAGENTS, BY COUNTRY, 2017–2021 (USD MILLION)
                     TABLE 21 EXPORT DATA FOR DIAGNOSTICS AND CLINICAL REAGENTS, BY COUNTRY, 2017–2021 (TONS)
           5.14.3 TRADE ANALYSIS FOR IMMUNOASSAYS
                     TABLE 22 IMPORT DATA FOR HS CODE 902750, BY COUNTRY, 2017–2021 (USD MILLION)
 
6 GLOBAL PROTEOMICS MARKET SHARE, BY INSTRUMENTATION TECHNOLOGY (Page No. - 122)
    6.1 INTRODUCTION 
           6.1.1 PRICING ANALYSIS
                    TABLE 23 AVERAGE SELLING PRICE OF PRODUCTS AND SERVICES, 2022 (USD)
                    TABLE 24 MARKET, BY INSTRUMENTATION TECHNOLOGY, 2021–2028 (USD MILLION)
    6.2 SPECTROSCOPY 
          TABLE 25 PROTEOMICS CRO MARKET FOR SPECTROSCOPY, BY TYPE, 2021–2028 (USD MILLION)
          TABLE 26 MARKET FOR SPECTROSCOPY, BY REGION, 2021–2028 (USD MILLION)
          TABLE 27 NORTH AMERICA: MARKET FOR SPECTROSCOPY, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 28 EUROPE: MARKET FOR SPECTROSCOPY, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 29 ASIA PACIFIC: MARKET FOR SPECTROSCOPY, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 30 LATIN AMERICA: MARKET FOR SPECTROSCOPY, BY COUNTRY, 2021–2028 (USD MILLION)
           6.2.1 MASS SPECTROSCOPY
                    6.2.1.1 High specificity of mass spectroscopy to boost market
                                TABLE 31 MASS SPECTROSCOPY MARKET, BY REGION, 2021–2028 (USD MILLION)
                                TABLE 32 NORTH AMERICA: MASS SPECTROSCOPY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 33 EUROPE: MASS SPECTROSCOPY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 34 ASIA PACIFIC: MASS SPECTROSCOPY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 35 LATIN AMERICA: MASS SPECTROSCOPY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
           6.2.2 NMR SPECTROSCOPY
                    6.2.2.1 NMR experiments to evaluate physical, chemical, electronic, and structural information of proteins
                                TABLE 36 NMR SPECTROSCOPY MARKET, BY REGION, 2021–2028 (USD MILLION)
                                TABLE 37 NORTH AMERICA: NMR SPECTROSCOPY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 38 EUROPE: NMR SPECTROSCOPY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 39 ASIA PACIFIC: NMR SPECTROSCOPY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 40 LATIN AMERICA: NMR SPECTROSCOPY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
           6.2.3 CD SPECTROSCOPY
                    6.2.3.1 CD spectroscopy to examine changes in secondary structures of protein in response to environmental conditions
                                TABLE 41 CD SPECTROSCOPY MARKET, BY REGION, 2021–2028 (USD MILLION)
                                TABLE 42 NORTH AMERICA: CD SPECTROSCOPY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 43 EUROPE: CD SPECTROSCOPY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 44 ASIA PACIFIC: CD SPECTROSCOPY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 45 LATIN AMERICA: CD SPECTROSCOPY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
    6.3 CHROMATOGRAPHY 
          TABLE 46 PROTEOMICS INUSTRY FOR CHROMATOGRAPHY, BY TYPE, 2021–2028 (USD MILLION)
          TABLE 47 PROTEOMICS CRO MARKET FOR CHROMATOGRAPHY, BY REGION, 2021–2028 (USD MILLION)
          TABLE 48 NORTH AMERICA: MARKET FOR CHROMATOGRAPHY, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 49 EUROPE: MARKET FOR CHROMATOGRAPHY, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 50 ASIA PACIFIC: MARKET FOR CHROMATOGRAPHY, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 51 LATIN AMERICA: MARKET FOR CHROMATOGRAPHY, BY COUNTRY, 2021–2028 (USD MILLION)
           6.3.1 HPLC
                    6.3.1.1 Growing biopharmaceutical industry and increasing investments in life science research
                                TABLE 52 HPLC MARKET, BY REGION, 2021–2028 (USD MILLION)
                                TABLE 53 NORTH AMERICA: HPLC MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 54 EUROPE: HPLC MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 55 ASIA PACIFIC: HPLC MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 56 LATIN AMERICA: HPLC MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
           6.3.2 ION CHROMATOGRAPHY
                    6.3.2.1 Ion chromatography to be most significant chromatographic technique for separation and purification of proteins
                                TABLE 57 ION CHROMATOGRAPHY MARKET, BY REGION, 2021–2028 (USD MILLION)
                                TABLE 58 NORTH AMERICA: ION CHROMATOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 59 EUROPE: ION CHROMATOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 60 ASIA PACIFIC: ION CHROMATOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 61 LATIN AMERICA: ION CHROMATOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
           6.3.3 AFFINITY CHROMATOGRAPHY
                    6.3.3.1 Affinity chromatography to quantify protein expression using isotope-coded affinity tags
                                TABLE 62 AFFINITY CHROMATOGRAPHY MARKET, BY REGION, 2021–2028 (USD MILLION)
                                TABLE 63 NORTH AMERICA: AFFINITY CHROMATOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 64 EUROPE: AFFINITY CHROMATOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 65 ASIA PACIFIC: AFFINITY CHROMATOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 66 LATIN AMERICA: AFFINITY CHROMATOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
           6.3.4 SUPERCRITICAL FLUID CHROMATOGRAPHY
                    6.3.4.1 Supercritical fluid chromatography to separate complex protein mixtures with high efficiency and speed
                                TABLE 67 SUPERCRITICAL FLUID CHROMATOGRAPHY MARKET, BY REGION, 2021–2028 (USD MILLION)
                                TABLE 68 NORTH AMERICA: SUPERCRITICAL FLUID CHROMATOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 69 EUROPE: SUPERCRITICAL FLUID CHROMATOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 70 ASIA PACIFIC: SUPERCRITICAL FLUID CHROMATOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 71 LATIN AMERICA: SUPERCRITICAL FLUID CHROMATOGRAPHY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
    6.4 ELECTROPHORESIS 
          TABLE 72 MARKET FOR ELECTROPHORESIS, BY TYPE, 2021–2028 (USD MILLION)
          TABLE 73 MARKET FOR ELECTROPHORESIS, BY REGION, 2021–2028 (USD MILLION)
          TABLE 74 NORTH AMERICA: MARKET FOR ELECTROPHORESIS, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 75 EUROPE: MARKET FOR ELECTROPHORESIS, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 76 ASIA PACIFIC: MARKET FOR ELECTROPHORESIS, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 77 LATIN AMERICA: MARKET FOR ELECTROPHORESIS, BY COUNTRY, 2021–2028 (USD MILLION)
           6.4.1 GEL ELECTROPHORESIS
                    6.4.1.1 Increasing demand for gel electrophoresis in proteomics research and personalized medicine
                                TABLE 78 GEL ELECTROPHORESIS MARKET, BY REGION, 2021–2028 (USD MILLION)
                                TABLE 79 NORTH AMERICA: GEL ELECTROPHORESIS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 80 EUROPE: GEL ELECTROPHORESIS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 81 ASIA PACIFIC: GEL ELECTROPHORESIS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 82 LATIN AMERICA: GEL ELECTROPHORESIS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
           6.4.2 CAPILLARY ELECTROPHORESIS
                    6.4.2.1 Rise in applications of capillary electrophoresis in therapeutics and drug discovery
                                TABLE 83 CAPILLARY ELECTROPHORESIS MARKET, BY REGION, 2021–2028 (USD MILLION)
                                TABLE 84 NORTH AMERICA: CAPILLARY ELECTROPHORESIS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 85 EUROPE: CAPILLARY ELECTROPHORESIS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 86 ASIA PACIFIC: CAPILLARY ELECTROPHORESIS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 87 LATIN AMERICA: CAPILLARY ELECTROPHORESIS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
    6.5 PROTEIN MICROARRAYS 
          TABLE 88 PROTEOMICS CRO MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2021–2028 (USD MILLION)
          TABLE 89 MARKET FOR PROTEIN MICROARRAYS, BY REGION, 2021–2028 (USD MILLION)
          TABLE 90 NORTH AMERICA: MARKET FOR PROTEIN MICROARRAYS, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 91 EUROPE: MARKET FOR PROTEIN MICROARRAYS, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 92 ASIA PACIFIC: MARKET FOR PROTEIN MICROARRAYS, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 93 LATIN AMERICA: MARKET FOR PROTEIN MICROARRAYS, BY COUNTRY, 2021–2028 (USD MILLION)
           6.5.1 BIOCHIPS
                    TABLE 94 BIOCHIPS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 95 BIOCHIPS MARKET, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 96 NORTH AMERICA: BIOCHIPS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 97 EUROPE: BIOCHIPS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 98 ASIA PACIFIC: BIOCHIPS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 99 LATIN AMERICA: BIOCHIPS MARKET, BY REGION, 2021–2028 (USD MILLION)
                    6.5.1.1 Lab-on-chips
                               6.5.1.1.1 Rising applications of lab-on-chips in microfabrication and nanotechnology development
                                              TABLE 100 LAB-ON-CHIPS MARKET, BY REGION, 2021–2028 (USD MILLION)
                                              TABLE 101 NORTH AMERICA: LAB-ON-CHIPS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                              TABLE 102 EUROPE: LAB-ON-CHIPS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                              TABLE 103 ASIA PACIFIC: LAB-ON-CHIPS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                              TABLE 104 LATIN AMERICA: LAB-ON-CHIPS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    6.5.1.2 Protein chips
                               6.5.1.2.1 Competitive advantage over conventional protein analysis tools
                                              TABLE 105 PROTEIN CHIPS MARKET, BY REGION, 2021–2028 (USD MILLION)
                                              TABLE 106 NORTH AMERICA: PROTEIN CHIPS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                              TABLE 107 EUROPE: PROTEIN CHIPS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                              TABLE 108 ASIA PACIFIC: PROTEIN CHIPS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                              TABLE 109 LATIN AMERICA: PROTEIN CHIPS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
           6.5.2 MICROARRAY INSTRUMENTS
                    TABLE 110 MICROARRAY INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 111 MICROARRAY INSTRUMENTS MARKET, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 112 NORTH AMERICA: MICROARRAY INSTRUMENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 113 EUROPE: MICROARRAY INSTRUMENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 114 ASIA PACIFIC: MICROARRAY INSTRUMENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 115 LATIN AMERICA: MICROARRAY INSTRUMENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    6.5.2.1 Integrated systems
                               6.5.2.1.1 Integrated systems to enable high-throughput and reproducible analysis of large numbers of proteins
                                              TABLE 116 INTEGRATED SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION)
                                              TABLE 117 NORTH AMERICA: INTEGRATED SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                              TABLE 118 EUROPE: INTEGRATED SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                              TABLE 119 ASIA PACIFIC: INTEGRATED SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                              TABLE 120 LATIN AMERICA: INTEGRATED SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    6.5.2.2 Microarray scanners
                               6.5.2.2.1 Microarray scanners to provide high-quality analysis and cost efficiency
                                              TABLE 121 MICROARRAY SCANNERS MARKET, BY REGION, 2021–2028 (USD MILLION)
                                              TABLE 122 NORTH AMERICA: MICROARRAY SCANNERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                              TABLE 123 EUROPE: MICROARRAY SCANNERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                              TABLE 124 ASIA PACIFIC: MICROARRAY SCANNERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                              TABLE 125 LATIN AMERICA: MICROARRAY SCANNERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    6.5.2.3 Arrayers
                               6.5.2.3.1 Technological advancements to make microarray spotters ideal for large-scale arraying projects
                                              TABLE 126 ARRAYERS MARKET, BY REGION, 2021–2028 (USD MILLION)
                                              TABLE 127 NORTH AMERICA: ARRAYERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                              TABLE 128 EUROPE: ARRAYERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                              TABLE 129 ASIA PACIFIC: ARRAYERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                              TABLE 130 LATIN AMERICA: ARRAYERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
    6.6 X-RAY CRYSTALLOGRAPHY 
           6.6.1 INCREASED NEED FOR HIGH-RESOLUTION INFORMATION ON PROTEIN STRUCTURES WITH X-RAY CRYSTALLOGRAPHY TO AID MARKET
                    TABLE 131 MARKET FOR X-RAY CRYSTALLOGRAPHY, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 132 NORTH AMERICA: MARKET FOR X-RAY CRYSTALLOGRAPHY, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 133 EUROPE: MARKET FOR X-RAY CRYSTALLOGRAPHY, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 134 ASIA PACIFIC: MARKET FOR X-RAY CRYSTALLOGRAPHY, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 135 LATIN AMERICA: MARKET FOR X-RAY CRYSTALLOGRAPHY, BY COUNTRY, 2021–2028 (USD MILLION)
    6.7 SURFACE PLASMON RESONANCE 
           6.7.1 ABILITY TO MEASURE BINDING AFFINITIES AND KINETICS OF COMPLEXES TO PROPEL MARKET
                    TABLE 136 MARKET FOR SURFACE PLASMON RESONANCE, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 137 NORTH AMERICA: MARKET FOR SURFACE PLASMON RESONANCE, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 138 EUROPE: MARKET FOR SURFACE PLASMON RESONANCE, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 139 ASIA PACIFIC: MARKET FOR SURFACE PLASMON RESONANCE, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 140 LATIN AMERICA: MARKET FOR SURFACE PLASMON RESONANCE, BY COUNTRY, 2021–2028 (USD MILLION)
    6.8 PROTEIN FRACTIONATION 
           6.8.1 PROTEIN FRACTIONATION TO ENABLE EFFECTIVE SEPARATION OF THOUSANDS OF PROTEINS IN COMPLEX MIXTURES
                    TABLE 141 MARKET FOR PROTEIN FRACTIONATION, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 142 NORTH AMERICA: MARKET FOR PROTEIN FRACTIONATION, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 143 EUROPE: MARKET FOR PROTEIN FRACTIONATION, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 144 ASIA PACIFIC: MARKET FOR PROTEIN FRACTIONATION, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 145 LATIN AMERICA: MARKET FOR PROTEIN FRACTIONATION, BY COUNTRY, 2021–2028 (USD MILLION)
    6.9 OTHER TECHNOLOGIES 
          TABLE 146 MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2021–2028 (USD MILLION)
          TABLE 147 NORTH AMERICA: MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 148 EUROPE: MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 149 ASIA PACIFIC: MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 150 LATIN AMERICA: MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2021–2028 (USD MILLION)
 
7 GLOBAL PROTEOMICS MARKET FORECAST, BY REAGENT (Page No. - 201)
    7.1 INTRODUCTION 
          TABLE 151 PROTEOMICS CRO MARKET, BY REAGENT, 2021–2028 (USD MILLION)
    7.2 IMMUNOASSAY REAGENTS 
           7.2.1 IMMUNOASSAY REAGENTS TO DOMINATE MARKET DURING FORECAST PERIOD
                    TABLE 152 MARKET FOR IMMUNOASSAY REAGENTS, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 153 NORTH AMERICA: MARKET FOR IMMUNOASSAY REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 154 EUROPE: MARKET FOR IMMUNOASSAY REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 155 ASIA PACIFIC: MARKET FOR IMMUNOASSAY REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 156 LATIN AMERICA: MARKET FOR IMMUNOASSAY REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)
    7.3 SPECTROSCOPY REAGENTS 
           7.3.1 INCREASED ADOPTION OF MS-BASED APPROACHES IN PROTEOMICS TO DRIVE MARKET
                    TABLE 157 MARKET FOR SPECTROSCOPY REAGENTS, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 158 NORTH AMERICA: MARKET FOR SPECTROSCOPY REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 159 EUROPE: MARKET FOR SPECTROSCOPY REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 160 ASIA PACIFIC: MARKET FOR SPECTROSCOPY REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 161 LATIN AMERICA: MARKET FOR SPECTROSCOPY REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)
    7.4 CHROMATOGRAPHY REAGENTS 
           7.4.1 INCREASING DEMAND FOR PROTEIN PURIFICATION TO AID MARKET
                    TABLE 162 MARKET FOR CHROMATOGRAPHY REAGENTS, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 163 NORTH AMERICA: MARKET FOR CHROMATOGRAPHY REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 164 EUROPE: MARKET FOR CHROMATOGRAPHY REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 165 ASIA PACIFIC: MARKET FOR CHROMATOGRAPHY REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 166 LATIN AMERICA: MARKET FOR CHROMATOGRAPHY REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)
    7.5 PROTEIN MICROARRAY REAGENTS 
           7.5.1 INCREASED FOCUS ON ANALYZING PROTEIN INTERACTIONS TO INCREASE USE OF PROTEIN MICROARRAY REAGENTS
                    TABLE 167 MARKET FOR PROTEIN MICROARRAY REAGENTS, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 168 NORTH AMERICA: MARKET FOR PROTEIN MICROARRAY REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 169 EUROPE: MARKET FOR PROTEIN MICROARRAY REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 170 ASIA PACIFIC: MARKET FOR PROTEIN MICROARRAY REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 171 LATIN AMERICA: MARKET FOR PROTEIN MICROARRAY REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)
    7.6 X-RAY CRYSTALLOGRAPHY REAGENTS 
           7.6.1 X-RAY CRYSTALLOGRAPHY TO BE ESSENTIAL IN PROTEIN STRUCTURE DETERMINATION
                    TABLE 172 MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 173 NORTH AMERICA: MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 174 EUROPE: MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 175 ASIA PACIFIC: MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 176 LATIN AMERICA: MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)
    7.7 ELECTROPHORESIS REAGENTS 
           7.7.1 INCREASING DEMAND FOR 2D ELECTROPHORESIS TO PROPEL MARKET
                    TABLE 177 MARKET FOR ELECTROPHORESIS REAGENTS, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 178 NORTH AMERICA: MARKET FOR ELECTROPHORESIS REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 179 EUROPE: MARKET FOR ELECTROPHORESIS REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 180 ASIA PACIFIC: MARKET FOR ELECTROPHORESIS REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 181 LATIN AMERICA: MARKET FOR ELECTROPHORESIS REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)
    7.8 PROTEIN FRACTIONATION REAGENTS 
           7.8.1 INCREASING NEED FOR PROTEIN SEPARATION FROM COMPLEX MIXTURES TO AUGMENT MARKET
                    TABLE 182 MARKET FOR PROTEIN FRACTIONATION REAGENTS, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 183 NORTH AMERICA: MARKET FOR PROTEIN FRACTIONATION REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 184 EUROPE: MARKET FOR PROTEIN FRACTIONATION REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 185 ASIA PACIFIC: MARKET FOR PROTEIN FRACTIONATION REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 186 LATIN AMERICA: MARKET FOR PROTEIN FRACTIONATION REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)
    7.9 OTHER REAGENTS 
          TABLE 187 MARKET FOR OTHER REAGENTS, BY REGION, 2021–2028 (USD MILLION)
          TABLE 188 NORTH AMERICA: MARKET FOR OTHER REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 189 EUROPE: MARKET FOR OTHER REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 190 ASIA PACIFIC: MARKET FOR OTHER REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 191 LATIN AMERICA: MARKET FOR OTHER REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)
 
8 GLOBAL PROTEOMICS MARKET FORECAST, BY SERVICE & SOFTWARE (Page No. - 228)
    8.1 INTRODUCTION 
          TABLE 192 PROTEOMICS CRO MARKET, BY SOFTWARE & SERVICE, 2021–2028 (USD MILLION)
    8.2 CORE PROTEOMICS SERVICES 
          TABLE 193 MARKET FOR CORE PROTEOMICS SERVICES, BY TYPE, 2021–2028 (USD MILLION)
          TABLE 194 MARKET FOR CORE PROTEOMICS SERVICES, BY REGION, 2021–2028 (USD MILLION)
          TABLE 195 NORTH AMERICA: MARKET FOR CORE PROTEOMICS SERVICES, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 196 EUROPE: MARKET FOR CORE PROTEOMICS SERVICES, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 197 ASIA PACIFIC: MARKET FOR CORE PROTEOMICS SERVICES, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 198 LATIN AMERICA: MARKET FOR CORE PROTEOMICS SERVICES, BY COUNTRY, 2021–2028 (USD MILLION)
           8.2.1 PROTEIN IDENTIFICATION SERVICES
                    8.2.1.1 Rising demand for molecular weight analysis to boost the global proteomics market growth
                                TABLE 199 PROTEIN IDENTIFICATION SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION)
                                TABLE 200 NORTH AMERICA: PROTEIN IDENTIFICATION SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 201 EUROPE: PROTEIN IDENTIFICATION SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 202 ASIA PACIFIC: PROTEIN IDENTIFICATION SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 203 LATIN AMERICA: PROTEIN IDENTIFICATION SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
           8.2.2 PROTEIN CHARACTERIZATION SERVICES
                    8.2.2.1 Increased focus on study of complex protein structure, drug development, and PTMs to drive segment
                                TABLE 204 PROTEIN CHARACTERIZATION SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION)
                                TABLE 205 NORTH AMERICA: PROTEIN CHARACTERIZATION SERVICES MARKET, BY COUNTRY 2021–2028 (USD MILLION)
                                TABLE 206 EUROPE: PROTEIN CHARACTERIZATION SERVICES MARKET, BY COUNTRY 2021–2028 (USD MILLION)
                                TABLE 207 ASIA PACIFIC: PROTEIN CHARACTERIZATION SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 208 LATIN AMERICA: PROTEIN CHARACTERIZATION SERVICES MARKET, BY COUNTRY 2021–2028 (USD MILLION)
           8.2.3 QUANTITATIVE PROTEOMICS SERVICES
                    8.2.3.1 Quantitative proteomics to be critical for understanding protein expression and modifications
                                TABLE 209 QUANTITATIVE PROTEOMICS SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION)
                                TABLE 210 NORTH AMERICA: QUANTITATIVE PROTEOMICS SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 211 EUROPE: QUANTITATIVE PROTEOMICS SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 212 ASIA PACIFIC: QUANTITATIVE PROTEOMICS SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 213 LATIN AMERICA: QUANTITATIVE PROTEOMICS SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
           8.2.4 PROTEIN PURIFICATION SERVICES
                    8.2.4.1 Protein purification services to improve overall proteome analysis
                                TABLE 214 PROTEIN PURIFICATION SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION)
                                TABLE 215 NORTH AMERICA: PROTEIN PURIFICATION SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 216 EUROPE: PROTEIN PURIFICATION SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 217 ASIA PACIFIC: PROTEIN PURIFICATION SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 218 LATIN AMERICA: PROTEIN PURIFICATION SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
           8.2.5 PROTEIN SEPARATION SERVICES
                    8.2.5.1 Protein separation services to characterize large-sized proteomes of different sizes
                                TABLE 219 PROTEIN SEPARATION SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION)
                                TABLE 220 NORTH AMERICA: PROTEIN SEPARATION SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 221 EUROPE: PROTEIN SEPARATION SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 222 ASIA PACIFIC: PROTEIN SEPARATION SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 223 LATIN AMERICA: PROTEIN SEPARATION SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
           8.2.6 PROTEIN SEQUENCING SERVICES
                    8.2.6.1 Identification and characterization of post-translational modifications to determine characterizations of proteins
                                TABLE 224 PROTEIN SEQUENCING SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION)
                                TABLE 225 NORTH AMERICA: PROTEIN SEQUENCING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 226 EUROPE: PROTEIN SEQUENCING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 227 ASIA PACIFIC: PROTEIN SEQUENCING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 228 LATIN AMERICA: PROTEIN SEQUENCING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
           8.2.7 CUSTOM ASSAY SERVICES
                    8.2.7.1 Custom assays to improve validation or consistency of protein analysis procedures
                                TABLE 229 CUSTOM ASSAY SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION)
                                TABLE 230 NORTH AMERICA: CUSTOM ASSAY SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 231 EUROPE: CUSTOM ASSAY SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 232 ASIA PACIFIC: CUSTOM ASSAY SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 233 LATIN AMERICA: CUSTOM ASSAY SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
    8.3 BIOINFORMATICS SOFTWARE & SERVICES 
          TABLE 234 MARKET FOR BIOINFORMATICS SOFTWARE & SERVICES, BY TYPE, 2021–2028 (USD MILLION)
           8.3.1 BIOINFORMATICS SERVICES
                    8.3.1.1 Bioinformatics services to dominate market during study period
                                TABLE 235 BIOINFORMATICS SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION)
                                TABLE 236 NORTH AMERICA: BIOINFORMATICS SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 237 EUROPE: BIOINFORMATICS SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 238 ASIA PACIFIC: BIOINFORMATICS SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 239 LATIN AMERICA: BIOINFORMATICS SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION
           8.3.2 BIOINFORMATICS TOOLS
                    8.3.2.1 Increased need for data management to drive segment
                                TABLE 240 BIOINFORMATICS TOOLS MARKET, BY REGION, 2021–2028 (USD MILLION)
                                TABLE 241 NORTH AMERICA: BIOINFORMATICS TOOLS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 242 EUROPE: BIOINFORMATICS TOOLS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 243 ASIA PACIFIC: BIOINFORMATICS TOOLS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 244 LATIN AMERICA: BIOINFORMATICS TOOLS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
           8.3.3 BIOINFORMATICS DATABASES
                    8.3.3.1 Growing need to store proteomics data and integrate other omics databases to fuel market
                                TABLE 245 BIOINFORMATICS DATABASES MARKET, BY REGION, 2021–2028 (USD MILLION)
                                TABLE 246 NORTH AMERICA: BIOINFORMATICS DATABASES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 247 EUROPE: BIOINFORMATICS DATABASES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 248 ASIA PACIFIC: BIOINFORMATICS DATABASES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 249 LATIN AMERICA: BIOINFORMATICS DATABASES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
 
9 GLOBAL PROTEOMICS MARKET FORECAST, BY APPLICATION (Page No. - 266)
    9.1 INTRODUCTION 
          TABLE 250 PROTEOMICS CRO MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
    9.2 CLINICAL DIAGNOSTICS 
          TABLE 251 MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2021–2028 (USD MILLION)
          TABLE 252 MARKET FOR CLINICAL DIAGNOSTICS, BY REGION, 2021–2028 (USD MILLION)
          TABLE 253 NORTH AMERICA: MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 254 EUROPE: MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 255 ASIA PACIFIC: MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 256 LATIN AMERICA: MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2021–2028 (USD MILLION)
           9.2.1 CANCER
                    9.2.1.1 Increasing investments in cancer research to drive market
                                TABLE 257 CANCER MARKET, BY REGION, 2021–2028 (USD MILLION)
                                TABLE 258 NORTH AMERICA: CANCER MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 259 EUROPE: CANCER MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 260 ASIA PACIFIC: CANCER MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 261 LATIN AMERICA: CANCER MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
           9.2.2 INFECTIOUS DISEASES
                    9.2.2.1 Growing prevalence of infectious diseases in emerging economices to propel market
                                TABLE 262 INFECTIOUS DISEASES MARKET, BY REGION, 2021–2028 (USD MILLION)
                                TABLE 263 NORTH AMERICA: INFECTIOUS DISEASES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 264 EUROPE: INFECTIOUS DISEASES MARKET, BY COUNTRY 2021–2028 (USD MILLION)
                                TABLE 265 ASIA PACIFIC: INFECTIOUS DISEASES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 266 LATIN AMERICA: INFECTIOUS DISEASES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
           9.2.3 DIABETES
                    9.2.3.1 Rising investments in diabetes research to drive the global proteomics market growth
                                TABLE 267 DIABETES MARKET, BY REGION, 2021–2028 (USD MILLION)
                                TABLE 268 NORTH AMERICA: DIABETES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 269 EUROPE: DIABETES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 270 ASIA PACIFIC: DIABETES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 271 LATIN AMERICA: DIABETES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
           9.2.4 NEUROLOGICAL DISORDERS
                    9.2.4.1 Increasing clinical trials and research in neurological disorders to fuel market
                                TABLE 272 NEUROLOGICAL DISORDERS MARKET, BY REGION, 2021–2028 (USD MILLION)
                                TABLE 273 NORTH AMERICA: NEUROLOGICAL DISORDERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 274 EUROPE: NEUROLOGICAL DISORDERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 275 ASIA PACIFIC: NEUROLOGICAL DISORDERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 276 LATIN AMERICA: NEUROLOGICAL DISORDERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
           9.2.5 AUTOIMMUNE DISEASES
                    9.2.5.1 Increasing demand for proteomics in diagnosis of autoimmune diseases to boost market
                                TABLE 277 AUTOIMMUNE DISEASES MARKET, BY REGION, 2021–2028 (USD MILLION)
                                TABLE 278 NORTH AMERICA: AUTOIMMUNE DISEASES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 279 EUROPE: AUTOIMMUNE DISEASES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 280 ASIA PACIFIC: AUTOIMMUNE DISEASES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 281 LATIN AMERICA: AUTOIMMUNE DISEASES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
           9.2.6 CARDIOVASCULAR DISEASES
                    9.2.6.1 High burden of cardiovascular diseases globally to increase development of more reliable proteomics tools
                                TABLE 282 CARDIOVASCULAR DISEASES MARKET, BY REGION, 2021–2028 (USD MILLION)
                                TABLE 283 NORTH AMERICA: CARDIOVASCULAR DISEASES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 284 EUROPE: CARDIOVASCULAR DISEASES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 285 ASIA PACIFIC: CARDIOVASCULAR DISEASES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 286 LATIN AMERICA: CARDIOVASCULAR DISEASES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
           9.2.7 OTHER CLINICAL DIAGNOSTIC APPLICATIONS
                    TABLE 287 OTHER CLINICAL DIAGNOSTIC APPLICATIONS MARKET, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 288 NORTH AMERICA: OTHER CLINICAL DIAGNOSTIC APPLICATIONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 289 EUROPE: OTHER CLINICAL DIAGNOSTIC APPLICATIONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 290 ASIA PACIFIC: OTHER CLINICAL DIAGNOSTIC APPLICATIONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 291 LATIN AMERICA: OTHER CLINICAL DIAGNOSTIC APPLICATIONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
    9.3 DRUG DISCOVERY & DEVELOPMENT 
          TABLE 292 MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2021–2028 (USD MILLION)
          TABLE 293 MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2021–2028 (USD MILLION)
          TABLE 294 NORTH AMERICA: MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 295 EUROPE: MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 296 ASIA PACIFIC: MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 297 LATIN AMERICA: MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2021–2028 (USD MILLION)
           9.3.1 TARGET DISCOVERY
                    9.3.1.1 Increasing demand for personalized medicine to support market
                                TABLE 298 TARGET DISCOVERY MARKET, BY REGION, 2021–2028 (USD MILLION)
                                TABLE 299 NORTH AMERICA: TARGET DISCOVERY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 300 EUROPE: TARGET DISCOVERY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 301 ASIA PACIFIC: TARGET DISCOVERY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 302 LATIN AMERICA: TARGET DISCOVERY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
           9.3.2 LEAD IDENTIFICATION
                    9.3.2.1 Lead identification to be most revenue-generating process among drug discovery & development processes
                                TABLE 303 LEAD IDENTIFICATION MARKET, BY REGION, 2021–2028 (USD MILLION)
                                TABLE 304 NORTH AMERICA: LEAD IDENTIFICATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 305 EUROPE: LEAD IDENTIFICATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 306 ASIA PACIFIC: LEAD IDENTIFICATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 307 LATIN AMERICA: LEAD IDENTIFICATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
           9.3.3 LEAD OPTIMIZATION
                    9.3.3.1 Lead optimization to require state-of-the-art informatics systems for transparent presentation and analysis
                                TABLE 308 LEAD OPTIMIZATION MARKET, BY REGION, 2021–2028 (USD MILLION)
                                TABLE 309 NORTH AMERICA: LEAD OPTIMIZATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 310 EUROPE: LEAD OPTIMIZATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 311 ASIA PACIFIC: LEAD OPTIMIZATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 312 LATIN AMERICA: LEAD OPTIMIZATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
           9.3.4 PRECLINICAL STUDIES
                    9.3.4.1 Preclinical studies to facilitate transparent presentation and analysis of latest data for rapid reprioritization of synthetic targets
                                TABLE 313 PRECLINICAL STUDIES MARKET, BY REGION, 2021–2028 (USD MILLION)
                                TABLE 314 NORTH AMERICA: PRECLINICAL STUDIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 315 EUROPE: PRECLINICAL STUDIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 316 ASIA PACIFIC: PRECLINICAL STUDIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 317 LATIN AMERICA: PRECLINICAL STUDIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
    9.4 OTHER APPLICATIONS 
          TABLE 318 MARKET FOR OTHER APPLICATIONS, BY REGION, 2021–2028 (USD MILLION)
          TABLE 319 NORTH AMERICA: MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 320 EUROPE: MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 321 ASIA PACIFIC: MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 322 LATIN AMERICA: MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
 
10 GLOBAL PROTEOMICS MARKET FORECAST, BY END USER (Page No. - 312)
     10.1 INTRODUCTION 
             TABLE 323 PROTEOMICS CRO MARKET, BY END USER, 2021–2028 (USD MILLION)
     10.2 HOSPITALS 
             10.2.1 RISING ADOPTION OF PROTEOMICS FOR DISEASE DIAGNOSIS TO DRIVE MARKET
                        TABLE 324 MARKET FOR HOSPITALS, BY REGION, 2021–2028 (USD MILLION)
                        TABLE 325 NORTH AMERICA: MARKET FOR HOSPITALS, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 326 EUROPE: MARKET FOR HOSPITALS, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 327 ASIA PACIFIC: MARKET FOR HOSPITALS, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 328 LATIN AMERICA: MARKET FOR HOSPITALS, BY COUNTRY, 2021–2028 (USD MILLION)
     10.3 CLINICAL LABORATORIES 
             10.3.1 INCREASING OUTSOURCING OF DIAGNOSTICS TESTS BY HOSPITALS TO SUPPORT SEGMENT
                        TABLE 329 MARKET FOR CLINICAL LABORATORIES, BY REGION, 2021–2028 (USD MILLION)
                        TABLE 330 NORTH AMERICA: MARKET FOR CLINICAL LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 331 EUROPE: MARKET FOR CLINICAL LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 332 ASIA PACIFIC: MARKET FOR CLINICAL LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 333 LATIN AMERICA: MARKET FOR CLINICAL LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION)
     10.4 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 
             10.4.1 RISING FOCUS ON DRUG DISCOVERY IN BIOPHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES TO DRIVE MARKET
                        TABLE 334 MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2021–2028 (USD MILLION)
                        TABLE 335 NORTH AMERICA: MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 336 EUROPE: MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 337 ASIA PACIFIC: MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 338 LATIN AMERICA: MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
     10.5 ACADEMIC RESEARCH LABORATORIES 
             10.5.1 INCREASING RESEARCH FUNDING FOR PRECISION MEDICINES TO AUGMENT MARKET
                        TABLE 339 MARKET FOR ACADEMIC RESEARCH LABORATORIES, BY REGION, 2021–2028 (USD MILLION)
                        TABLE 340 NORTH AMERICA: MARKET FOR ACADEMIC RESEARCH LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 341 EUROPE: MARKET FOR ACADEMIC RESEARCH LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 342 ASIA PACIFIC: MARKET FOR ACADEMIC RESEARCH LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 343 LATIN AMERICA: MARKET FOR ACADEMIC RESEARCH LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION)
     10.6 OTHER END USERS 
             TABLE 344 MARKET FOR OTHER END USERS, BY REGION, 2021–2028 (USD MILLION)
             TABLE 345 NORTH AMERICA: MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION)
             TABLE 346 EUROPE: MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION)
             TABLE 347 ASIA PACIFIC: MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION)
             TABLE 348 LATIN AMERICA: MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION)
 
11 GLOBAL PROTEOMICS MARKET FORECAST, BY REGION (Page No. - 330)
     11.1 INTRODUCTION 
             TABLE 349 PROTEOMICS CRO MARKET, BY REGION, 2021–2028 (USD MILLION)
     11.2 NORTH AMERICA 
             11.2.1 NORTH AMERICA: IMPACT OF ECONOMIC RECESSION
                        FIGURE 30 NORTH AMERICA: PROTEOMICS MARKET SNAPSHOT
                        TABLE 350 NORTH AMERICA: MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 351 NORTH AMERICA: PROTEOMICS INUSTRY, BY INSTRUMENTATION TECHNOLOGY, 2021–2028 (USD MILLION)
                        TABLE 352 NORTH AMERICA: MARKET FOR SPECTROSCOPY, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 353 NORTH AMERICA: MARKET FOR CHROMATOGRAPHY, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 354 NORTH AMERICA: MARKET FOR ELECTROPHORESIS, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 355 NORTH AMERICA: MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 356 NORTH AMERICA: BIOCHIPS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 357 NORTH AMERICA: MICROARRAY INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 358 NORTH AMERICA: PROTEOMICS CRO MARKET, BY REAGENT, 2021–2028 (USD MILLION)
                        TABLE 359 NORTH AMERICA: MARKET, BY SOFTWARE & SERVICE, 2021–2028 (USD MILLION)
                        TABLE 360 NORTH AMERICA: MARKET FOR CORE PROTEOMICS SERVICES, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 361 NORTH AMERICA: MARKET FOR BIOINFORMATICS SOFTWARE & SERVICES, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 362 NORTH AMERICA: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                        TABLE 363 NORTH AMERICA: MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 364 NORTH AMERICA: MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 365 NORTH AMERICA: PROTEOMICS MARKET OVERVIEW, BY END USER, 2021–2028 (USD MILLION)
             11.2.2 US
                        11.2.2.1 US to dominate North American proteomics market during forecast period
                                      TABLE 366 US: PROTEOMICS MARKET OVERVIEW, BY INSTRUMENTATION TECHNOLOGY, 2021–2028 (USD MILLION)
                                      TABLE 367 US: MARKET FOR SPECTROSCOPY, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 368 US: PROTEOMICS INUSTRY FOR CHROMATOGRAPHY, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 369 US: MARKET FOR ELECTROPHORESIS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 370 US: MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 371 US: BIOCHIPS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 372 US: MICROARRAY INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 373 US: MARKET, BY REAGENT, 2021–2028 (USD MILLION)
                                      TABLE 374 US: PROTEOMICS CRO MARKET, BY SOFTWARE & SERVICE, 2021–2028 (USD MILLION)
                                      TABLE 375 US: MARKET FOR CORE PROTEOMICS SERVICES, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 376 US: MARKET FOR BIOINFORMATICS SOFTWARE & SERVICE, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 377 US: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 378 US: MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 379 US: MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 380 US: PROTEOMICS MARKET OVERVIEW, BY END USER, 2021–2028 (USD MILLION)
             11.2.3 CANADA
                        11.2.3.1 Strong infrastructure and increased availability of funding for biomedical research to support market
                                      TABLE 381 CANADA: PROTEOMICS MARKET OVERVIEW, BY INSTRUMENTATION TECHNOLOGY, 2021–2028 (USD MILLION)
                                      TABLE 382 CANADA: MARKET FOR SPECTROSCOPY, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 383 CANADA: PROTEOMICS INUSTRY FOR CHROMATOGRAPHY, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 384 CANADA: MARKET FOR ELECTROPHORESIS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 385 CANADA: MARKET FOR PROTEIN MICROARRAYS, 2021–2028 (USD MILLION)
                                      TABLE 386 CANADA: BIOCHIPS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 387 CANADA: MICROARRAY INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 388 CANADA: MARKET, BY REAGENT, 2021–2028 (USD MILLION)
                                      TABLE 389 CANADA: PROTEOMICS CRO MARKET, BY SOFTWARE & SERVICE, 2021–2028 (USD MILLION)
                                      TABLE 390 CANADA: MARKET FOR CORE PROTEOMICS SERVICES, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 391 CANADA: MARKET FOR BIOINFORMATICS SOFTWARE & SERVICE, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 392 CANADA: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 393 CANADA: MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 394 CANADA: MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 395 CANADA: PROTEOMICS MARKET OVERVIEW, BY END USER, 2021–2028 (USD MILLION)
     11.3 EUROPE 
             11.3.1 EUROPE: IMPACT OF RECESSION
                        TABLE 396 EUROPE: PROTEOMICS MARKET GROWTH, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 397 EUROPE: MARKET, BY INSTRUMENTATION TECHNOLOGY, 2021–2028 (USD MILLION)
                        TABLE 398 EUROPE: PROTEOMICS INUSTRY FOR SPECTROSCOPY, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 399 EUROPE: MARKET FOR CHROMATOGRAPHY, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 400 EUROPE: MARKET FOR ELECTROPHORESIS, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 401 EUROPE: MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 402 EUROPE: BIOCHIPS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 403 EUROPE: MICROARRAY INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 404 EUROPE: PROTEOMICS CRO MARKET, BY REAGENT, 2021–2028 (USD MILLION)
                        TABLE 405 EUROPE: MARKET, BY SOFTWARE & SERVICE, 2021–2028 (USD MILLION)
                        TABLE 406 EUROPE: MARKET FOR CORE PROTEOMICS SERVICES, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 407 EUROPE: MARKET FOR BIOINFORMATICS SOFTWARE & SERVICES, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 408 EUROPE: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                        TABLE 409 EUROPE: MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 410 EUROPE: MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 411 EUROPE: PROTEOMICS MARKET GROWTH, BY END USER, 2021–2028 (USD MILLION)
             11.3.2 GERMANY
                        11.3.2.1 Germany to be largest market for proteomics in European region during forecast period
                                      TABLE 412 GERMANY: PROTEOMICS MARKET GROWTH, BY INSTRUMENTATION TECHNOLOGY, 2021–2028 (USD MILLION)
                                      TABLE 413 GERMANY: MARKET FOR SPECTROSCOPY, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 414 GERMANY: PROTEOMICS INUSTRY FOR CHROMATOGRAPHY, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 415 GERMANY: MARKET FOR ELECTROPHORESIS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 416 GERMANY: MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 417 GERMANY: BIOCHIPS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 418 GERMANY: MICROARRAY INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 419 GERMANY: MARKET, BY REAGENT, 2021–2028 (USD MILLION)
                                      TABLE 420 GERMANY: PROTEOMICS CRO MARKET, BY SOFTWARE & SERVICE, 2021–2028 (USD MILLION)
                                      TABLE 421 GERMANY: MARKET FOR CORE PROTEOMICS SERVICES, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 422 GERMANY: MARKET FOR BIOINFORMATICS SOFTWARE & SERVICES, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 423 GERMANY: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 424 GERMANY: MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 425 GERMANY: MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 426 GERMANY: PROTEOMICS MARKET GROWTH, BY END USER, 2021–2028 (USD MILLION)
             11.3.3 UK
                        11.3.3.1 High prevalence of cancer and growth in life science industry to fuel market
                                      TABLE 427 UK: PROTEOMICS MARKET GROWTH, BY INSTRUMENTATION TECHNOLOGY 2021–2028 (USD MILLION)
                                      TABLE 428 UK: MARKET FOR SPECTROSCOPY, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 429 UK: PROTEOMICS INUSTRY FOR CHROMATOGRAPHY, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 430 UK: MARKET FOR ELECTROPHORESIS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 431 UK: MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 432 UK: BIOCHIPS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 433 UK: MICROARRAY INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 434 UK: MARKET, BY REAGENT, 2021–2028 (USD MILLION)
                                      TABLE 435 UK: MARKET, BY SOFTWARE & SERVICE, 2021–2028 (USD MILLION)
                                      TABLE 436 UK: PROTEOMICS CRO MARKET FOR CORE PROTEOMICS SERVICES, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 437 UK: MARKET FOR BIOINFORMATICS SOFTWARE & SERVICES, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 438 UK: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 439 UK: MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 440 UK: MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 441 UK: PROTEOMICS MARKET REPORT, BY END USER, 2021–2028 (USD MILLION)
             11.3.4 FRANCE
                        11.3.4.1 Development of new proteomics-based diagnostic tools and investments in life science R&D to drive market
                                      TABLE 442 FRANCE: PROTEOMICS MARKET REPORT, BY INSTRUMENTATION TECHNOLOGY, 2021–2028 (USD MILLION)
                                      TABLE 443 FRANCE: MARKET FOR SPECTROSCOPY, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 444 FRANCE: PROTEOMICS INUSTRY FOR CHROMATOGRAPHY, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 445 FRANCE: MARKET FOR ELECTROPHORESIS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 446 FRANCE: MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 447 FRANCE: BIOCHIPS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 448 FRANCE: MICROARRAY INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 449 FRANCE: MARKET, BY REAGENT, 2021–2028 (USD MILLION)
                                      TABLE 450 FRANCE: MARKET, BY SOFTWARE & SERVICE, 2021–2028 (USD MILLION)
                                      TABLE 451 FRANCE: PROTEOMICS CRO MARKET FOR CORE PROTEOMICS SERVICES, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 452 FRANCE: MARKET, FOR BIOINFORMATICS SOFTWARE & SERVICES, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 453 FRANCE: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 454 FRANCE: MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 455 FRANCE: MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 456 FRANCE: PROTEOMICS MARKET REPORT, BY END USER, 2021–2028 (USD MILLION)
             11.3.5 SWITZERLAND
                        11.3.5.1 Well-established pharmaceutical & biotechnology industry and increased investments in life science R&D infrastructure to augment market
                                      TABLE 457 SWITZERLAND: PROTEOMICS MARKET REPORT, BY INSTRUMENTATION TECHNOLOGY, 2021–2028 (USD MILLION)
                                      TABLE 458 SWITZERLAND: MARKET FOR SPECTROSCOPY, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 459 SWITZERLAND: PROTEOMICS INUSTRY FOR CHROMATOGRAPHY, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 460 SWITZERLAND: MARKET FOR ELECTROPHORESIS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 461 SWITZERLAND: MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 462 SWITZERLAND: BIOCHIPS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 463 SWITZERLAND: MICROARRAY INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 464 SWITZERLAND: MARKET, BY REAGENT, 2021–2028 (USD MILLION)
                                      TABLE 465 SWITZERLAND: MARKET, BY SOFTWARE & SERVICE, 2021–2028 (USD MILLION)
                                      TABLE 466 SWITZERLAND: PROTEOMICS CRO MARKET FOR CORE PROTEOMICS SERVICES, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 467 SWITZERLAND: MARKET FOR BIOINFORMATICS SOFTWARE & SERVICES, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 468 SWITZERLAND: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 469 SWITZERLAND: MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 470 SWITZERLAND: MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 471 SWITZERLAND: PROTEOMICS MARKET REPORT, BY END USER, 2021–2028 (USD MILLION)
             11.3.6 ITALY
                        11.3.6.1 Increase in federal grants and private funding programs to support projects on translational research
                                      TABLE 472 ITALY: PROTEOMICS MARKET ANALYSIS, BY INSTRUMENTATION TECHNOLOGY, 2021–2028 (USD MILLION)
                                      TABLE 473 ITALY: MARKET FOR SPECTROSCOPY, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 474 ITALY: PROTEOMICS INUSTRY FOR CHROMATOGRAPHY, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 475 ITALY: MARKET FOR ELECTROPHORESIS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 476 ITALY: MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 477 ITALY: BIOCHIPS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 478 ITALY: MICROARRAY INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 479 ITALY: MARKET, BY REAGENT, 2021–2028 (USD MILLION)
                                      TABLE 480 ITALY: MARKET, BY SOFTWARE & SERVICE, 2021–2028 (USD MILLION)
                                      TABLE 481 ITALY: PROTEOMICS CRO MARKET FOR CORE PROTEOMICS SERVICES, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 482 ITALY: MARKET FOR BIOINFORMATICS SOFTWARE & SERVICES, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 483 ITALY: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 484 ITALY: MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 485 ITALY: MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 486 ITALY: PROTEOMICS MARKET ANALYSIS, BY END USER, 2021–2028 (USD MILLION)
             11.3.7 SPAIN
                        11.3.7.1 Well-established network of research centers, universities, and hospitals to aid proteomics research
                                      TABLE 487 SPAIN: PROTEOMICS MARKET ANALYSIS, BY INSTRUMENTATION TECHNOLOGY, 2021–2028 (USD MILLION)
                                      TABLE 488 SPAIN: MARKET FOR SPECTROSCOPY, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 489 SPAIN: PROTEOMICS INUSTRY FOR CHROMATOGRAPHY, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 490 SPAIN: MARKET FOR ELECTROPHORESIS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 491 SPAIN: MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 492 SPAIN: BIOCHIPS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 493 SPAIN: MICROARRAY INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 494 SPAIN: MARKET, BY REAGENT, 2021–2028 (USD MILLION)
                                      TABLE 495 SPAIN: MARKET, BY SOFTWARE & SERVICE, 2021–2028 (USD MILLION)
                                      TABLE 496 SPAIN: PROTEOMICS CRO MARKET FOR CORE PROTEOMICS SERVICES, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 497 SPAIN: MARKET FOR BIOINFORMATICS SOFTWARE & SERVICES, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 498 SPAIN: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 499 SPAIN: MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 500 SPAIN: MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 501 SPAIN: PROTEOMICS MARKET ANALYSIS, BY END USER, 2021–2028 (USD MILLION)
             11.3.8 REST OF EUROPE
                        TABLE 502 REST OF EUROPE: PROTEOMICS MARKET ANALYSIS, BY INSTRUMENTATION TECHNOLOGY, 2021–2028 (USD MILLION)
                        TABLE 503 REST OF EUROPE: MARKET FOR SPECTROSCOPY, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 504 REST OF EUROPE: PROTEOMICS INUSTRY FOR CHROMATOGRAPHY, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 505 REST OF EUROPE: MARKET FOR ELECTROPHORESIS, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 506 REST OF EUROPE: MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 507 REST OF EUROPE: BIOCHIPS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 508 REST OF EUROPE: MICROARRAY INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 509 REST OF EUROPE: MARKET, BY REAGENT, 2021–2028 (USD MILLION)
                        TABLE 510 REST OF EUROPE: MARKET, BY SOFTWARE & SERVICE, 2021–2028 (USD MILLION)
                        TABLE 511 REST OF EUROPE: PROTEOMICS CRO MARKET FOR CORE PROTEOMICS SERVICES, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 512 REST OF EUROPE: MARKET FOR BIOINFORMATICS SOFTWARE & SERVICES, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 513 REST OF EUROPE: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                        TABLE 514 REST OF EUROPE: MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 515 REST OF EUROPE: MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 516 REST OF EUROPE: PROTEOMICS MARKET RESEARCH, BY END USER, 2021–2028 (USD MILLION)
     11.4 ASIA PACIFIC 
             11.4.1 ASIA PACIFIC: IMPACT OF ECONOMIC RECESSION
                        FIGURE 31 ASIA PACIFIC: PROTEOMICS MARKET SNAPSHOT
                        TABLE 517 ASIA PACIFIC: MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 518 ASIA PACIFIC: PROTEOMICS INUSTRY, BY INSTRUMENTATION TECHNOLOGY, 2021–2028 (USD MILLION)
                        TABLE 519 ASIA PACIFIC: MARKET FOR SPECTROSCOPY, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 520 ASIA PACIFIC: MARKET FOR CHROMATOGRAPHY, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 521 ASIA PACIFIC: MARKET FOR ELECTROPHORESIS, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 522 ASIA PACIFIC: MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 523 ASIA PACIFIC: BIOCHIPS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 524 ASIA PACIFIC: MICROARRAY INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 525 ASIA PACIFIC: MARKET, BY REAGENT, 2021–2028 (USD MILLION)
                        TABLE 526 ASIA PACIFIC: PROTEOMICS CRO MARKET, BY SOFTWARE & SERVICE, 2021–2028 (USD MILLION)
                        TABLE 527 ASIA PACIFIC: MARKET FOR CORE PROTEOMICS, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 528 ASIA PACIFIC: MARKET FOR BIOINFORMATICS SOFTWARE & SERVICES, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 529 ASIA PACIFIC: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                        TABLE 530 ASIA PACIFIC: MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 531 ASIA PACIFIC: MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 532 ASIA PACIFIC: PROTEOMICS MARKET RESEARCH, BY END USER, 2021–2028 (USD MILLION)
             11.4.2 CHINA
                        11.4.2.1 Heavy investments in life science industry and establishment of proteomics research centers to drive market
                                      TABLE 533 CHINA: PROTEOMICS MARKET RESEARCH, BY INSTRUMENTATION TECHNOLOGY, 2021–2028 (USD MILLION)
                                      TABLE 534 CHINA: MARKET FOR SPECTROSCOPY, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 535 CHINA: PROTEOMICS INUSTRY FOR CHROMATOGRAPHY, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 536 CHINA: MARKET FOR ELECTROPHORESIS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 537 CHINA: MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 538 CHINA: BIOCHIPS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 539 CHINA: MICROARRAY INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 540 CHINA: MARKET, BY REAGENT, 2021–2028 (USD MILLION)
                                      TABLE 541 CHINA: PROTEOMICS CRO MARKET, BY SOFTWARE & SERVICE, 2021–2028 (USD MILLION)
                                      TABLE 542 CHINA: MARKET FOR CORE PROTEOMICS SERVICES, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 543 CHINA: MARKET FOR BIOINFORMATICS SOFTWARE & SERVICES, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 544 CHINA: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 545 CHINA: MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 546 CHINA: MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 547 CHINA: PROTEOMICS MARKET RESEARCH, BY END USER, 2021–2028 (USD MILLION)
             11.4.3 JAPAN
                        11.4.3.1 Increased targeted funding for precision medicine research to support market
                                      TABLE 548 JAPAN: PROTEOMICS MARKET RESEARCH, BY INSTRUMENTATION TECHNOLOGY, 2021–2028 (USD MILLION)
                                      TABLE 549 JAPAN: MARKET FOR SPECTROSCOPY, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 550 JAPAN: PROTEOMICS INUSTRY FOR CHROMATOGRAPHY, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 551 JAPAN: MARKET FOR ELECTROPHORESIS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 552 JAPAN: MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 553 JAPAN: BIOCHIPS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 554 JAPAN: MICROARRAY INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 555 JAPAN: MARKET, BY REAGENT, 2021–2028 (USD MILLION)
                                      TABLE 556 JAPAN: MARKET, BY SOFTWARE & SERVICE, 2021–2028 (USD MILLION)
                                      TABLE 557 JAPAN: PROTEOMICS CRO MARKET FOR CORE PROTEOMICS SERVICES, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 558 JAPAN: MARKET FOR BIOINFORMATICS SOFTWARE & SERVICES, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 559 JAPAN: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 560 JAPAN: MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 561 JAPAN: MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 562 JAPAN: PROTEOMICS MARKET PREDICTION, BY END USER, 2021–2028 (USD MILLION)
             11.4.4 INDIA
                        11.4.4.1 Increasing number of proteomics and genomics research studies to support market
                                      TABLE 563 INDIA: PROTEOMICS MARKET PREDICTION, BY INSTRUMENTATION TECHNOLOGY 2021–2028 (USD MILLION)
                                      TABLE 564 INDIA: MARKET, FOR SPECTROSCOPY, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 565 INDIA: PROTEOMICS INUSTRY FOR CHROMATOGRAPHY, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 566 INDIA: MARKET FOR ELECTROPHORESIS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 567 INDIA: MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 568 INDIA: BIOCHIPS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 569 INDIA: MICROARRAY INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 570 INDIA: MARKET, BY REAGENT, 2021–2028 (USD MILLION)
                                      TABLE 571 INDIA: PROTEOMICS CRO MARKET BY SOFTWARE & SERVICE, 2021–2028 (USD MILLION)
                                      TABLE 572 INDIA: MARKET FOR CORE PROTEOMICS SERVICES, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 573 INDIA: MARKET FOR BIOINFORMATICS SOFTWARE & SERVICES, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 574 INDIA: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 575 INDIA: MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 576 INDIA: MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 577 INDIA: PROTEOMICS MARKET PREDICTION, BY END USER, 2021–2028 (USD MILLION)
             11.4.5 AUSTRALIA
                        11.4.5.1 Increasing focus of healthcare system on precision medicine to offer significant growth opportunities
                                      TABLE 578 AUSTRALIA: PROTEOMICS MARKET PREDICTION, BY INSTRUMENTATION TECHNOLOGY, 2021–2028 (USD MILLION)
                                      TABLE 579 AUSTRALIA: MARKET FOR SPECTROSCOPY, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 580 AUSTRALIA: PROTEOMICS INUSTRY FOR CHROMATOGRAPHY, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 581 AUSTRALIA: MARKET FOR ELECTROPHORESIS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 582 AUSTRALIA: MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 583 AUSTRALIA: BIOCHIPS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 584 AUSTRALIA: MICROARRAY INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 585 AUSTRALIA: MARKET, BY REAGENT, 2021–2028 (USD MILLION)
                                      TABLE 586 AUSTRALIA: PROTEOMICS CRO MARKET, BY SOFTWARE & SERVICE, 2021–2028 (USD MILLION)
                                      TABLE 587 AUSTRALIA: MARKET FOR CORE PROTEOMICS SERVICES, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 588 AUSTRALIA: MARKET FOR BIOINFORMATICS SOFTWARE & SERVICE, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 589 AUSTRALIA: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 590 AUSTRALIA: MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 591 AUSTRALIA: MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 592 AUSTRALIA: PROTEOMICS MARKET PREDICTION, BY END USER, 2021–2028 (USD MILLION)
             11.4.6 REST OF ASIA PACIFIC
                        TABLE 593 REST OF ASIA PACIFIC: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2021–2028 (USD MILLION)
                        TABLE 594 REST OF ASIA PACIFIC: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 595 REST OF ASIA PACIFIC: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 596 REST OF ASIA PACIFIC: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 597 REST OF ASIA PACIFIC: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 598 REST OF ASIA PACIFIC: BIOCHIPS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 599 REST OF ASIA PACIFIC: MICROARRAY INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 600 REST OF ASIA PACIFIC: PROTEOMICS MARKET, BY REAGENT, 2021–2028 (USD MILLION)
                        TABLE 601 REST OF ASIA PACIFIC: PROTEOMICS MARKET, BY SOFTWARE & SERVICE, 2021–2028 (USD MILLION)
                        TABLE 602 REST OF ASIA PACIFIC: PROTEOMICS MARKET FOR CORE PROTEOMICS SERVICES, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 603 REST OF ASIA PACIFIC: PROTEOMICS MARKET FOR BIOINFORMATICS SOFTWARE & SERVICES, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 604 REST OF ASIA PACIFIC: PROTEOMICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                        TABLE 605 REST OF ASIA PACIFIC: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS SERVICES, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 606 REST OF ASIA PACIFIC: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 607 REST OF ASIA PACIFIC: PROTEOMICS MARKET, BY END USER, 2021–2028 (USD MILLION)
     11.5 LATIN AMERICA 
             11.5.1 LATIN AMERICA: IMPACT OF ECONOMIC RECESSION
                        TABLE 608 LATIN AMERICA: PROTEOMICS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 609 LATIN AMERICA: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2021–2028 (USD MILLION)
                        TABLE 610 LATIN AMERICA: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 611 LATIN AMERICA: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 612 LATIN AMERICA: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 613 LATIN AMERICA: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 614 LATIN AMERICA: BIOCHIPS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 615 LATIN AMERICA: MICROARRAY INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 616 LATIN AMERICA: PROTEOMICS MARKET, BY REAGENT, 2021–2028 (USD MILLION)
                        TABLE 617 LATIN AMERICA: PROTEOMICS MARKET, BY SOFTWARE & SERVICE, 2021–2028 (USD MILLION)
                        TABLE 618 LATIN AMERICA: PROTEOMICS MARKET FOR CORE PROTEOMICS SERVICES, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 619 LATIN AMERICA: PROTEOMICS MARKET FOR BIOINFORMATICS SOFTWARE & SERVICES, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 620 LATIN AMERICA: PROTEOMICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                        TABLE 621 LATIN AMERICA: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 622 LATIN AMERICA: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 623 LATIN AMERICA: PROTEOMICS MARKET, BY END USER, 2021–2028 (USD MILLION)
             11.5.2 BRAZIL
                        11.5.2.1 Growing contract research and manufacturing activities to drive market
                                      TABLE 624 BRAZIL: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2021–2028 (USD MILLION)
                                      TABLE 625 BRAZIL: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 626 BRAZIL: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 627 BRAZIL: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 628 BRAZIL: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 629 BRAZIL: BIOCHIPS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 630 BRAZIL: MICROARRAY INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 631 BRAZIL: PROTEOMICS MARKET, BY REAGENT, 2021–2028 (USD MILLION)
                                      TABLE 632 BRAZIL: PROTEOMICS MARKET, BY SOFTWARE & SERVICE, 2021–2028 (USD MILLION)
                                      TABLE 633 BRAZIL: PROTEOMICS MARKET FOR CORE PROTEOMICS SERVICES, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 634 BRAZIL: PROTEOMICS MARKET FOR BIOINFORMATICS SOFTWARE & SERVICE, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 635 BRAZIL: PROTEOMICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 636 BRAZIL: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 637 BRAZIL: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 638 BRAZIL: PROTEOMICS MARKET, BY END USER, 2021–2028 (USD MILLION)
             11.5.3 MEXICO
                        11.5.3.1 Strong pharmaceutical industry and increased government support for proteomics research to augment market
                                      TABLE 639 MEXICO: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2021–2028 (USD MILLION)
                                      TABLE 640 MEXICO: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 641 MEXICO: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 642 MEXICO: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 643 MEXICO: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 644 MEXICO: BIOCHIPS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 645 MEXICO: MICROARRAY INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 646 MEXICO: PROTEOMICS MARKET, BY REAGENT, 2021–2028 (USD MILLION)
                                      TABLE 647 MEXICO: PROTEOMICS MARKET, BY SOLUTION & SERVICE, 2021–2028 (USD MILLION)
                                      TABLE 648 MEXICO: PROTEOMICS MARKET FOR CORE PROTEOMICS SERVICES, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 649 MEXICO: PROTEOMICS MARKET FOR BIOINFORMATICS SOFTWARE & SERVICES, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 650 MEXICO: PROTEOMICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 651 MEXICO: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 652 MEXICO: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 653 MEXICO: PROTEOMICS MARKET, BY END USER, 2021–2028 (USD MILLION)
             11.5.4 REST OF LATIN AMERICA
                        TABLE 654 REST OF LATIN AMERICA: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2021–2028 (USD MILLION)
                        TABLE 655 REST OF LATIN AMERICA: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 656 REST OF LATIN AMERICA: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 657 REST OF LATIN AMERICA: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 658 REST OF LATIN AMERICA: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 659 REST OF LATIN AMERICA: BIOCHIPS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 660 REST OF LATIN AMERICA: MICROARRAY INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 661 REST OF LATIN AMERICA: PROTEOMICS MARKET, BY REAGENT, 2021–2028 (USD MILLION)
                        TABLE 662 REST OF LATIN AMERICA: PROTEOMICS MARKET, BY SOFTWARE & SERVICE, 2021–2028 (USD MILLION)
                        TABLE 663 REST OF LATIN AMERICA: PROTEOMICS MARKET FOR CORE PROTEOMICS SERVICES, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 664 REST OF LATIN AMERICA: PROTEOMICS MARKET FOR BIOINFORMATICS SOFTWARE & SERVICES, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 665 REST OF LATIN AMERICA: PROTEOMICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                        TABLE 666 REST OF LATIN AMERICA: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 667 REST OF LATIN AMERICA: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 668 REST OF LATIN AMERICA: PROTEOMICS MARKET, BY END USER, 2021–2028 (USD MILLION)
     11.6 MIDDLE EAST & AFRICA 
             11.6.1 INCREASING PARTNERSHIPS AMONG GLOBAL PLAYERS WITH GOVERNMENT ORGANIZATIONS TO FUEL MARKET
                        TABLE 669 MIDDLE EAST & AFRICA: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2021–2028 (USD MILLION)
                        TABLE 670 MIDDLE EAST & AFRICA: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 671 MIDDLE EAST & AFRICA: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 672 MIDDLE EAST & AFRICA: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 673 MIDDLE EAST & AFRICA: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 674 MIDDLE EAST & AFRICA: BIOCHIPS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 675 MIDDLE EAST & AFRICA: MICROARRAY INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 676 MIDDLE EAST & AFRICA: PROTEOMICS MARKET, BY REAGENT, 2021–2028 (USD MILLION)
                        TABLE 677 MIDDLE EAST & AFRICA: PROTEOMICS MARKET, BY SOFTWARE & SERVICE, 2021–2028 (USD MILLION)
                        TABLE 678 MIDDLE EAST & AFRICA: PROTEOMICS MARKET FOR CORE PROTEOMICS SERVICES, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 679 MIDDLE EAST & AFRICA: PROTEOMICS MARKET FOR BIOINFORMATICS SOFTWARE & SERVICES, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 680 MIDDLE EAST & AFRICA: PROTEOMICS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                        TABLE 681 MIDDLE EAST & AFRICA: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 682 MIDDLE EAST & AFRICA: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 683 MIDDLE EAST & AFRICA: PROTEOMICS MARKET, BY END USER, 2021–2028 (USD MILLION)
 
12 COMPETITIVE LANDSCAPE (Page No. - 508)
     12.1 INTRODUCTION 
     12.2 STRATEGIES ADOPTED BY KEY PLAYERS 
             FIGURE 32 GLOBAL PROTEOMICS MARKET: STRATEGIES ADOPTED BY KEY PLAYERS
     12.3 REVENUE SHARE ANALYSIS 
             FIGURE 33 REVENUE ANALYSIS OF KEY PLAYERS, 2020–2022
     12.4 MARKET SHARE ANALYSIS 
             FIGURE 34 PROTEOMICS CRO MARKET SHARE ANALYSIS OF KEY PLAYERS, 2022
             TABLE 684 PROTEOMICS MARKET: DEGREE OF COMPETITION
     12.5 COMPANY EVALUATION QUADRANT FOR KEY PLAYERS 
             12.5.1 STARS
             12.5.2 EMERGING LEADERS
             12.5.3 PERVASIVE PLAYERS
             12.5.4 PARTICIPANTS
                        FIGURE 35 GLOBAL PROTEOMICS MARKET: COMPANY EVALUATION MATRIX FOR KEY PLAYERS, 2022
     12.6 COMPETITIVE BENCHMARKING OF TOP 25 PLAYERS 
             12.6.1 INDUSTRY FOOTPRINT OF COMPANIES (25 COMPANIES)
                        TABLE 685 INDUSTRY FOOTPRINT ANALYSIS OF KEY PLAYERS IN PROTEOMICS MARKET
             12.6.2 PRODUCTS AND SERVICE FOOTPRINT OF COMPANIES (25 COMPANIES)
                        TABLE 686 PRODUCT AND SERVICE FOOTPRINT ANALYSIS OF KEY PLAYERS IN GLOBAL PROTEOMICS MARKET
             12.6.3 GEOGRAPHICAL FOOTPRINT OF COMPANIES (25 COMPANIES)
                        TABLE 687 GEOGRAPHICAL FOOTPRINT ANALYSIS OF PLAYERS IN PROTEOMICS MARKET
     12.7 COMPANY EVALUATION QUADRANT FOR START-UPS/SMES 
             12.7.1 PROGRESSIVE COMPANIES
             12.7.2 STARTING BLOCKS
             12.7.3 RESPONSIVE COMPANIES
             12.7.4 DYNAMIC COMPANIES
                        FIGURE 36 GLOBAL PROTEOMICS MARKET: COMPANY EVALUATION MATRIX FOR START-UPS/SMES, 2022
     12.8 COMPETITIVE BENCHMARKING OF START-UPS/SMES 
             TABLE 688 PROTEOMICS SERVICES MARKET: DETAILED LIST OF KEY START-UPS/SMES
             TABLE 689 PROTEOMICS MARKET: COMPETITIVE BENCHMARKING OF START-UPS/SMES
     12.9 COMPETITIVE SCENARIO AND TRENDS 
             12.9.1 KEY PRODUCT LAUNCHES
                        TABLE 690 GLOBAL PROTEOMICS MARKET: KEY PRODUCT LAUNCHES, JANUARY 2020–APRIL 2023
             12.9.2 KEY DEALS
                        TABLE 691 PROTEOMICS MARKET: KEY DEALS, JANUARY 2020–APRIL 2023
             12.9.3 OTHER KEY DEVELOPMENTS
                        TABLE 692 GLOBAL PROTEOMICS MARKET: OTHER KEY DEVELOPMENTS, JANUARY 2020–APRIL 2023
 
13 COMPANY PROFILES (Page No. - 524)
     13.1 KEY PLAYERS 
(Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)*
             13.1.1 THERMO FISHER SCIENTIFIC INC.
                        TABLE 693 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
                        FIGURE 37 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2022)
             13.1.2 AGILENT TECHNOLOGIES, INC.
                        TABLE 694 AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW
                        FIGURE 38 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2022)
             13.1.3 MERCK KGAA
                        TABLE 695 MERCK KGAA: COMPANY OVERVIEW
                        FIGURE 39 MERCK KGAA: COMPANY SNAPSHOT (2022)
             13.1.4 DANAHER
                        TABLE 696 DANAHER: COMPANY OVERVIEW
                        FIGURE 40 DANAHER: COMPANY SNAPSHOT (2022)
             13.1.5 WATERS CORPORATION
                        TABLE 697 WATERS CORPORATION: COMPANY OVERVIEW
                        FIGURE 41 WATERS CORPORATION: COMPANY SNAPSHOT (2022)
             13.1.6 BIO-RAD LABORATORIES, INC.
                        TABLE 698 BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW
                        FIGURE 42 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2022)
             13.1.7 BRUKER CORPORATION
                        TABLE 699 BRUKER CORPORATION: COMPANY OVERVIEW
                        FIGURE 43 BRUKER CORPORATION: COMPANY SNAPSHOT (2022)
             13.1.8 PERKINELMER, INC.
                        TABLE 700 PERKINELMER, INC.: COMPANY OVERVIEW
                        FIGURE 44 PERKINELMER, INC.: COMPANY SNAPSHOT (2022)
             13.1.9 SHIMADZU CORPORATION
                        TABLE 701 SHIMADZU CORPORATION: COMPANY OVERVIEW
                        FIGURE 45 SHIMADZU CORPORATION: COMPANY SNAPSHOT (2022)
             13.1.10 ILLUMINA, INC.
                        TABLE 702 ILLUMINA, INC.: COMPANY OVERVIEW
                        FIGURE 46 ILLUMINA, INC.: COMPANY SNAPSHOT (2022)
             13.1.11 PROMEGA CORPORATION
                        TABLE 703 PROMEGA CORPORATION: COMPANY OVERVIEW
             13.1.12 EUROFINS SCIENTIFIC
                        TABLE 704 EUROFINS SCIENTIFIC: COMPANY OVERVIEW
                        FIGURE 47 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2022)
             13.1.13 QIAGEN N.V.
                        TABLE 705 QIAGEN N.V.: COMPANY OVERVIEW
                        FIGURE 48 QIAGEN N.V.: COMPANY SNAPSHOT (2022)
             13.1.14 CHARLES RIVER LABORATORIES
                        TABLE 706 CHARLES RIVER LABORATORIES: COMPANY OVERVIEW
                        FIGURE 49 CHARLES RIVER LABORATORIES: COMPANY SNAPSHOT (2022)
             13.1.15 PROTAGENE PROTEIN SERVICES
                        TABLE 707 PROTAGENE PROTEIN SERVICES: COMPANY OVERVIEW
*Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies.
     13.2 OTHER PLAYERS 
             13.2.1 CREATIVE PROTEOMICS
             13.2.2 HORIBA CORPORATION
             13.2.3 SENGENICS
             13.2.4 BIOMAX INFORMATICS AG
             13.2.5 WUXI NEXTCODE
             13.2.6 FIOS GENOMICS
             13.2.7 GENEWIZ
             13.2.8 MEDGENOME LABS
             13.2.9 BIOGNOSYS AG
             13.2.10 MACROGEN INC.
 
14 APPENDIX (Page No. - 596)
     14.1 DISCUSSION GUIDE 
     14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 
     14.3 CUSTOMIZATION OPTIONS 
     14.4 RELATED REPORTS 
     14.5 AUTHOR DETAILS 

This study involved four major activities in estimating the current size of the proteomics market. Exhaustive secondary research was carried out to collect information on the market, its peer markets, and its parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. The top-down and other approaches were employed to estimate the complete market size (proteomics market size). After that, market breakdown and data triangulation procedures were used to estimate the market size of segments and subsegments.

Secondary Research

Secondary research was used mainly to identify and collect information for the extensive, technical, market-oriented, and commercial study of the proteomics market. The secondary sources referred to for this research study include publications from government and private sources such as the Indian Pharmaceutical Association (IPA), the Pharmaceutical Research and Manufacturers of America (PhRMA), the European Federation of Pharmaceutical Industries and Associations (EFPIA), Central Drugs Standard Control Organization (CDSCO), Indian Brand Equity Foundation (IBEF), European Medicines Agency (EMA), Global Cancer Observatory (GCO), American Chemical Society (ACS), National Center for Biotechnology Information (NCBI), Food and Drug Administration (FDA), Biotechnology and Biological Sciences Research Council (BBSRC), Pharmaceutical Research and Manufacturers of America (PhRMA), and the World Journal of Pharmaceutical Sciences, Company Websites, Annual Reports, SEC Filings, Press Releases, Investor Presentations, Journals, Expert Interviews, MarketsandMarkets Analysis. Secondary data was collected and analyzed to arrive at the overall size of the global proteomics market, which was then validated by primary research.

Primary Research

In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify the critical qualitative and quantitative information as well as assess future prospects of the market. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is a breakdown of the primary respondents:

Proteomics Market Size, and Share

To know about the assumptions considered for the study, download the pdf brochure

Proteomics Market Size Estimation

A top-down approach was used to estimate and validate the total size of the proteomics market. This method was also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the total proteomics market size includes the following:

  • The key players in the industry and market have been identified through extensive secondary research
  • The revenues generated from the proteomics business of leading players have been determined through primary and secondary research
  • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources

Proteomics Market Size, and Share

To know about the assumptions considered for the study, Request for Free Sample Report

Global Proteomics market size: Top-Down Approach

Proteomics Market Size, and Share

Data Triangulation

After arriving at the overall proteomics market size from the market size estimation process, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

Market Definition

Proteomics is the complete evaluation of the structure and function of proteins to understand an organism’s nature. It is the systemic identification and characterization of proteins along with their sequence, abundance, post-translational modifications, interactions, activity, subcellular localization, and structure. The market study includes the assessment of various instruments, reagents, software, and services used in proteomics.

Key Stakeholders

  • Life sciences instrumentation and reagent companies
  • Pharmaceutical and biotechnology companies
  • Proteomics database and software providers
  • Proteomics service providers
  • Research and consulting firms
  • Academic medical centers
  • Government research organizations 
  • Clinical research institutes
  • Contract Research Organizations

Report Objectives

  • To define, describe, and forecast the global proteomics market based on the instrumentation technologies, reagents, software & services, application, end-user, and region
  • To provide detailed information regarding the major factors influencing the growth of the market (such as drivers, restraints, challenges, and opportunities)
  • To strategically analyze micro markets with respect to individual growth trends, future prospects, and contributions to the overall proteomics market
  • To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of the market segments with respect to five main regions, namely, North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
  • To strategically profile the key players and comprehensively analyze their product & service portfolios, market positions, and core competencies
  • To track and analyze competitive developments such as product launches, acquisitions, expansions, agreements, collaborations, and R&D activities in the proteomics market.

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for this report:

Geographic Analysis

  • Further breakdown of the Rest of Europe proteomics market into respective countries
  • Further breakdown of the Rest of Asia Pacific proteomics market into respective countries
  • Further breakdown of the Rest of Latin America proteomics market into respective countries

Company Information

  • Detailed analysis and profiling of additional market players (Up to 5)
  • An additional five company profiles
Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Request Customization

Instant Answers with GPT - Ask Now!

Ask real questions. Get complete answers !
Report Code
BT 2341
Published ON
May, 2023
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Proteomics Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2024 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status Website Feedback